bioAffinity Technologies (BIAF) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.73, -5.81% vs the prior close of $3.96.
- Volume 100.27K shares, 0.0x its 50-day average (light).
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
BIAF slides 5.8% to $3.73. Closed at $3.73, -5.81% vs the prior close of $3.96. Day range $3.63–$3.95, opened at $3.95.
BIAF daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — BIAF slides 5.8% to $3.73
- Closed at $3.73, -5.81% vs the prior close of $3.96. Day range $3.63–$3.95, opened at $3.95.
- Volume was 100.27K shares, 0.0x its 50-day average of 4.74M — lighter than usual.
- Price is -45.5% vs its 50-day average ($6.85) and -81.4% vs its 200-day average ($20.04).
- 52-week range $3.23–$80.70; today's close sits at 1% of that range, 95.4% below the 52-week high.
Oct 15, 2026 — BIAF jumps 11.2% to $3.96
- Closed at $3.96, +11.24% vs the prior close of $3.56. Day range $3.41–$4.10, opened at $3.47.
- Volume was 274.70K shares, 0.1x its 50-day average of 4.73M — lighter than usual.
- Price is -42.9% vs its 50-day average ($6.93) and -80.3% vs its 200-day average ($20.11).
- 52-week range $3.23–$80.70; today's close sits at 1% of that range, 95.1% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 — BIAF dips 1.8% to $3.56, a 52-week low, 5 down days in a row
- Closed at $3.56, -1.79% vs the prior close of $3.62. Day range $3.41–$3.68, opened at $3.42.
- Volume was 114.90K shares, 0.0x its 50-day average of 4.73M — lighter than usual.
- Price is -49.2% vs its 50-day average ($7.01) and -82.4% vs its 200-day average ($20.18).
- 52-week range $3.23–$80.70; today's close sits at 0% of that range, 95.6% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — BIAF slides 7.1% to $3.62, a 52-week low, 4 down days in a row
- Closed at $3.62, -7.05% vs the prior close of $3.90. Day range $3.23–$3.74, opened at $3.52.
- Volume was 887.30K shares, 0.2x its 50-day average of 4.71M — lighter than usual.
- Price is -49.0% vs its 50-day average ($7.11) and -82.1% vs its 200-day average ($20.25).
- 52-week range $3.23–$80.70; today's close sits at 1% of that range, 95.5% below the 52-week high.
- That makes 4 straight losses.
- SEC filings that day: 8-K.
Oct 12, 2026 — BIAF slides 17.5% to $3.90, a 52-week low, 3 down days in a row
- Closed at $3.90, -17.46% vs the prior close of $4.72. Day range $3.76–$4.75, opened at $4.75.
- Volume was 283.20K shares, 0.1x its 50-day average of 4.71M — lighter than usual.
- Price is -45.9% vs its 50-day average ($7.21) and -80.8% vs its 200-day average ($20.33).
- 52-week range $3.76–$80.70; today's close sits at 0% of that range, 95.2% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — BIAF slides 16.2% to $4.72, a 1-month low
- Closed at $4.72, -16.22% vs the prior close of $5.64. Day range $4.68–$5.48, opened at $5.41.
- Volume was 651.50K shares, 0.1x its 50-day average of 4.69M — lighter than usual.
- Price is -35.5% vs its 50-day average ($7.32) and -76.8% vs its 200-day average ($20.40).
- 52-week range $4.56–$80.70; today's close sits at 0% of that range, 94.1% below the 52-week high.
- SEC filings that day: 8-K, 424B5, 424B5.
Oct 8, 2026 — BIAF slides 8.4% to $5.64 on 8.8x normal volume
- Closed at $5.64, -8.44% vs the prior close of $6.16. Day range $5.50–$9.38, opened at $6.35.
- Volume was 35.25M shares, 8.8x its 50-day average of 3.99M — unusually heavy trading.
- Price is -24.0% vs its 50-day average ($7.42) and -72.4% vs its 200-day average ($20.47).
- 52-week range $4.56–$80.70; today's close sits at 1% of that range, 93.0% below the 52-week high.
- SEC filings that day: 8-K.
Oct 7, 2026 — BIAF rises 1.7% to $6.16
- Closed at $6.16, +1.65% vs the prior close of $6.06. Day range $5.86–$6.28, opened at $5.90.
- Volume was 87.60K shares, 0.0x its 50-day average of 3.99M — lighter than usual.
- Price is -17.7% vs its 50-day average ($7.48) and -70.0% vs its 200-day average ($20.53).
- 52-week range $4.56–$80.70; today's close sits at 2% of that range, 92.4% below the 52-week high.
Oct 6, 2026 — BIAF dips 2.1% to $6.06
- Closed at $6.06, -2.10% vs the prior close of $6.19. Day range $5.90–$6.60, opened at $6.56.
- Volume was 255.40K shares, 0.1x its 50-day average of 3.98M — lighter than usual.
- Price is -19.7% vs its 50-day average ($7.55) and -70.6% vs its 200-day average ($20.60).
- 52-week range $4.56–$80.70; today's close sits at 2% of that range, 92.5% below the 52-week high.
- SEC filings that day: 8-K.
Oct 5, 2026 — BIAF rises 2.2% to $6.19
- Closed at $6.19, +2.23% vs the prior close of $6.05. Day range $5.85–$6.20, opened at $5.93.
- Volume was 105.40K shares, 0.0x its 50-day average of 3.98M — lighter than usual.
- Price is -18.9% vs its 50-day average ($7.63) and -70.0% vs its 200-day average ($20.66).
- 52-week range $4.56–$80.70; today's close sits at 2% of that range, 92.3% below the 52-week high.
Oct 2, 2026 — BIAF dips 1.5% to $6.05, 5 down days in a row
- Closed at $6.05, -1.46% vs the prior close of $6.14. Day range $5.90–$6.24, opened at $6.06.
- Volume was 154.60K shares, 0.0x its 50-day average of 3.98M — lighter than usual.
- Price is -21.4% vs its 50-day average ($7.71) and -70.8% vs its 200-day average ($20.73).
- 52-week range $4.56–$80.70; today's close sits at 2% of that range, 92.5% below the 52-week high.
- That makes 5 straight losses.
BIAF latest news & SEC filings
Every SEC filing by or about BIAF in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 13, 2026 · Form PRER14A — PRER14A filing
PRER14A filing
Oct 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 8.01 — Reported other events the company considers important.
Oct 9, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 9, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 29, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 8, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade BIAF
- Last results release: Aug 7, 2026 (8-K Item 2.02). Previous ones: May 8, 2026, Mar 13, 2026, Nov 14, 2025. Based on that rhythm, the next report is likely around Nov 6, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 6.97% (largest 18.3%). That is a volatile stock.
- Liquidity: about 2.07M shares (≈$7.71M) trade per day on average.
- 52-week position: $3.73 vs a range of $3.23–$80.70 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:15 on Aug 24, 2026, 1:30 on Sep 19, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 15, 2026; 8-K Oct 13, 2026; 8-K Oct 9, 2026.
- Share count: 8.10M shares outstanding (Aug 3, 2026), -71.5% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Services-Commercial Physical & Biological Research.
BIAF market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.95 | 3.95 | 3.63 | 3.73 | 100.27K |
| Oct 15, 2026 | 3.47 | 4.10 | 3.41 | 3.96 | 274.70K |
| Oct 14, 2026 | 3.42 | 3.68 | 3.41 | 3.56 | 114.90K |
| Oct 13, 2026 | 3.52 | 3.74 | 3.23 | 3.62 | 887.30K |
| Oct 12, 2026 | 4.75 | 4.75 | 3.76 | 3.90 | 283.20K |
| Oct 9, 2026 | 5.41 | 5.48 | 4.68 | 4.72 | 651.50K |
| Oct 8, 2026 | 6.35 | 9.38 | 5.50 | 5.64 | 35.25M |
| Oct 7, 2026 | 5.90 | 6.28 | 5.86 | 6.16 | 87.60K |
| Oct 6, 2026 | 6.56 | 6.60 | 5.90 | 6.06 | 255.40K |
| Oct 5, 2026 | 5.93 | 6.20 | 5.85 | 6.19 | 105.40K |
| Oct 2, 2026 | 6.06 | 6.24 | 5.90 | 6.05 | 154.60K |
| Oct 1, 2026 | 6.56 | 6.86 | 6.07 | 6.14 | 246.90K |
| Sep 30, 2026 | 6.56 | 7.00 | 6.56 | 6.56 | 108.10K |
| Sep 29, 2026 | 7.31 | 7.34 | 6.66 | 6.88 | 149.40K |
| Sep 28, 2026 | 7.74 | 8.00 | 7.27 | 7.41 | 481.00K |
| Sep 25, 2026 | 7.82 | 7.96 | 7.67 | 7.93 | 126.20K |
| Sep 24, 2026 | 7.67 | 8.00 | 7.50 | 7.83 | 218.70K |
| Sep 23, 2026 | 8.40 | 8.55 | 7.82 | 7.94 | 204.80K |
| Sep 22, 2026 | 8.28 | 9.14 | 8.26 | 8.56 | 874.30K |
| Sep 21, 2026 | 8.39 | 8.80 | 7.37 | 7.70 | 749.10K |
About bioAffinity Technologies
bioAffinity Technologies (BIAF) is listed on the Nasdaq and classified by the SEC under “Services-Commercial Physical & Biological Research”. Its business address is in SAN ANTONIO, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1712762.
BIAF board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BIAF financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $6.16M | $-14.91M | -8.66 | $-9.33M |
| Dec 31, 2024 | $9.36M | $-9.04M | -22.50 | $-7.26M |
| Dec 31, 2023 | $2.53M | $-7.94M | -0.91 | $-6.04M |
| Dec 31, 2022 | $4.80K | $-8.15M | -1.81 | $-4.07M |
| Dec 31, 2021 | — | $-6.33M | — | $-2.05M |
Latest balance sheet: total assets $7.62M, total liabilities $3.85M, cash $2.43M (as of Jun 30, 2026).
BIAF earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 7, 2026 | 8-K Item 2.02 (results) | $7.65 |
| May 8, 2026 | 8-K Item 2.02 (results) | $30.45 |
| Mar 13, 2026 | 8-K Item 2.02 (results) | $31.80 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $27.60 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $114.75 |
| May 15, 2025 | 8-K Item 2.02 (results) | $92.70 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $117.00 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $598.50 |
| Jul 9, 2024 | 8-K Item 2.02 (results) | — |
| May 16, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
| Mar 5, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Commercial Physical & Biological Research
Iqvia (IQV)Charles River Laboratories International (CRL)Incyte (INCY)Icon (ICLR)Medpace (MEDP)Absci (ABSI)OmniAb (OABI)Nrc Health (NRC)Maxcyte (MXCT)iSpecimen (ISPC)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BIAF
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.